Elevance Health (ELV) free cash flow was $3.2B in FY2025 (-30% YoY). The tables below show the complete quarterly and annual free cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Free Cash Flow
Fiscal Year
Free Cash Flow
YoY
2025
$3.2B
-30%
2024
$4.6B
-33%
2023
$6.8B
-7%
2022
$7.2B
-0%
2021
$7.3B
+46%
2019
$5.0B
+90%
2018
$2.6B
-23%
2017
$3.4B
+26%
2016
$2.7B
-25%
2015
$3.6B
+35%
2014
$2.7B
+10%
2013
$2.4B
+9%
2012
$2.2B
-23%
2011
$2.9B
+196%
2010
$965M
-64%
2009
$2.7B
+21%
2008
$2.2B
-46%
2007
$4.0B
Recent Quarterly Free Cash Flow
Quarter
Free Cash Flow
Q2 2026
$1.6B
Q1 2026
$4.1B
Q4 2025
-$209M
Q3 2025
$775M
Q2 2025
$1.8B
Q1 2025
$821M
Q4 2024
$384M
Q3 2024
$2.3B
Q2 2024
$124M
Q1 2024
$1.7B
Q4 2023
-$3.3B
Q3 2023
$2.3B
Source: ELV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.